Moneycontrol PRO

Dr Reddy’s: Primed by strong bets on complex pharma opportunities, good for risk takers

May 21, 2020 / 07:18 PM IST
Dr Reddy’s: Primed by strong bets on complex pharma opportunities, good for risk takers

PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook

Highlights - Diversified pharma major with strong pipeline in biologics, injectables - Q4 sales helped by developed markets performance - Beneficiary of steady product launches & regulatory resolutions - Near term focus remains on R&D investment and cost containment With the pharma sector a darling of investors in these COVID-19 infested times, we have deciphered Dr Reddy’s (CMP: Rs 570, Market cap: Rs 45,980 crore) March 2020 quarterly results. Also read: US FDA tailwind: Structural or situational? Chart: FY20 revenue break-up (image) Source: Dr Reddy’s Q4 result backed by US performance Q4 FY20 sales increased...

  • PRO Panorama

    Moneycontrol Pro Panorama | Indian stocks sitting pretty, but Asia feels the China chill

    Nov 28, 2022 / 03:31 PM IST

    In today’s edition of Moneycontrol Pro Panorama: It's advantage India amid China-Australia trade faceoff, small insurers accorded space to grow, shift in energy balance has to be fair, migrant footballers add spark to FIFA World Cup, and more

    Read Now
  • PRO Weekender

    Moneycontrol Pro Weekender | Outrunning the bear

    Nov 5, 2022 / 01:07 PM IST

    As the economies try their best to ward off a hard landing, India comes out as an outlier. It’s a classic case of just staying the course amid difficult times

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers